XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In- Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total Common Equity
Noncontrolling Interests in Subsidiaries
Balance at Oct. 31, 2021 $ 31,951 $ 71 $ 25,556 $ 12,963 $ (2,017) $ 36,573 $ (4,622)
Balance (in Shares) at Oct. 31, 2021   7,036          
Stock based compensation expense 5   5     5  
Vested share units granted to Directors 61   61     61  
Vested share units granted to Directors (in Shares)   2          
Distributions to noncontrolling interests in subsidiaries (19,700)         (19,700)
Net income (loss) 69,153     45,777   45,777 23,376
Dividends declared (703)     (703)   (703)  
Net unrealized loss on interest rate swap contracts 1,262       928 928 334
Balance at Jan. 31, 2022 82,029 $ 71 25,622 58,037 (1,089) 82,641 (612)
Balance (in Shares) at Jan. 31, 2022   7,038          
Balance at Oct. 31, 2021 31,951 $ 71 25,556 12,963 (2,017) 36,573 (4,622)
Balance (in Shares) at Oct. 31, 2021   7,036          
Net income (loss) 69,966            
Balance at Jul. 31, 2022 82,969 $ 71 25,697 58,102 99 83,969 (1,000)
Balance (in Shares) at Jul. 31, 2022   7,041          
Balance at Jan. 31, 2022 82,029 $ 71 25,622 58,037 (1,089) 82,641 (612)
Balance (in Shares) at Jan. 31, 2022   7,038          
Stock based compensation expense 5   5     5  
Vested share units granted to Directors 39   39     39  
Vested share units granted to Directors (in Shares)   2          
Distributions to noncontrolling interests in subsidiaries (180)         (180)
Net income (loss) (1,001)     (352)   (352) (649)
Dividends declared (704)     (704)   (704)  
Net unrealized loss on interest rate swap contracts 2,539       1,858 1,858 681
Balance at Apr. 30, 2022 82,727 $ 71 25,666 56,981 769 83,487 (760)
Balance (in Shares) at Apr. 30, 2022   7,040          
Stock based compensation expense 5   5     5  
Vested share units granted to Directors 26   26     26  
Vested share units granted to Directors (in Shares)   1          
Distributions to noncontrolling interests in subsidiaries (210)         (210)
Net income (loss) 1,814     1,121   1,121 693
Net unrealized loss on interest rate swap contracts (1,393)       (670) (670) (723)
Balance at Jul. 31, 2022 82,969 $ 71 25,697 58,102 99 83,969 (1,000)
Balance (in Shares) at Jul. 31, 2022   7,041          
Balance at Oct. 31, 2022 24,739 $ 73 30,635 (6,208) 1,409 25,909 (1,170)
Balance (in Shares) at Oct. 31, 2022   7,321          
Stock based compensation expense 5   5     5  
Vested share units granted to Directors 26   26     26  
Vested share units granted to Directors (in Shares)   2          
Stock options exercised 1,226 $ 1 1,225     1,226  
Stock options exercised (in Shares)   113          
Distributions to noncontrolling interests in subsidiaries (1,850)         (1,850)
Net income (loss) 46     419   419 (373)
Dividends declared (541)     (541)   (541)  
Net unrealized loss on interest rate swap contracts (450)       (450) (450)
Balance at Jan. 31, 2023 23,201 $ 74 31,891 (6,330) 959 26,594 (3,393)
Balance (in Shares) at Jan. 31, 2023   7,436          
Balance at Oct. 31, 2022 24,739 $ 73 30,635 (6,208) 1,409 25,909 (1,170)
Balance (in Shares) at Oct. 31, 2022   7,321          
Net income (loss) (1,086)            
Balance at Jul. 31, 2023 18,482 $ 74 32,074 (9,252) 1,241 24,137 (5,655)
Balance (in Shares) at Jul. 31, 2023   7,450          
Balance at Jan. 31, 2023 23,201 $ 74 31,891 (6,330) 959 26,594 (3,393)
Balance (in Shares) at Jan. 31, 2023   7,436          
Stock based compensation expense 5   5     5  
Stock awards granted to Directors 140   140     140  
Stock awards granted to Directors (in Shares)   9          
Stock options exercised 7   7     7  
Stock options exercised (in Shares)   1          
Distributions to noncontrolling interests in subsidiaries (204)         (204)
Net income (loss) (286)     97   97 (383)
Dividends declared (372)     (372)   (372)  
Net unrealized loss on interest rate swap contracts (107)       (107) (107)
Balance at Apr. 30, 2023 22,384 $ 74 32,043 (6,605) 852 26,364 (3,980)
Balance (in Shares) at Apr. 30, 2023   7,446          
Stock based compensation expense 1   1     1  
Stock options exercised 30   30     30  
Stock options exercised (in Shares)   4          
Distributions to noncontrolling interests in subsidiaries (1,241)         (1,241)
Net income (loss) (846)     (412)   (412) (434)
Dividends declared (2,235)     (2,235)   (2,235)  
Net unrealized loss on interest rate swap contracts 389       389 389  
Balance at Jul. 31, 2023 $ 18,482 $ 74 $ 32,074 $ (9,252) $ 1,241 $ 24,137 $ (5,655)
Balance (in Shares) at Jul. 31, 2023   7,450